Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To determine if Alvimopan during open or robotic radical cystectomy with urinary diversion
results in quicker return of bowel function (GI-2 recovery = time to upper [first toleration
of solid food] and lower [first bowel movement] gastrointestinal recovery) compared to
placebo.